Respiratory syncytial virus-associated mortality in a healthy 3-year-old child: a case report.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
27 11 2019
Historique:
received: 20 09 2019
accepted: 21 11 2019
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 18 11 2020
Statut: epublish

Résumé

Respiratory syncytial virus (RSV) is the most frequently identified pathogen in children with acute lower respiratory tract infection. Fatal cases have mainly been reported during the first 6 months of life or in the presence of comorbidity. A 47-month-old girl was admitted to the pediatric intensive care unit following sudden cardiopulmonary arrest occurring at home. The electrocardiogram showed cardiac asystole, which was refractory to prolonged resuscitation efforts. Postmortem analyses detected RSV by polymerase chain reaction in an abundant, exudative pericardial effusion. Histopathological examination was consistent with viral myoepicarditis, including an inflammatory process affecting cardiac nerves and ganglia. Molecular analysis of sudden unexplained death genes identified a heterozygous mutation in myosin light chain 2, which was also found in two other healthy members of the family. Additional expert interpretation of the cardiac histology confirmed the absence of arrhythmogenic right ventricular dysplasia or hypertrophic cardiomyopathy. RSV-related sudden death in a normally developing child of this age is exceptional. This case highlights the risk of extrapulmonary manifestations associated with this infection, particularly arrhythmia induced by inflammatory phenomena affecting the cardiac autonomic nervous system. The role of the mutation in this context is uncertain, and it is therefore necessary to continue to assess how this pathogenic variant contributes to unexpected sudden death in childhood.

Sections du résumé

BACKGROUND
Respiratory syncytial virus (RSV) is the most frequently identified pathogen in children with acute lower respiratory tract infection. Fatal cases have mainly been reported during the first 6 months of life or in the presence of comorbidity.
CASE PRESENTATION
A 47-month-old girl was admitted to the pediatric intensive care unit following sudden cardiopulmonary arrest occurring at home. The electrocardiogram showed cardiac asystole, which was refractory to prolonged resuscitation efforts. Postmortem analyses detected RSV by polymerase chain reaction in an abundant, exudative pericardial effusion. Histopathological examination was consistent with viral myoepicarditis, including an inflammatory process affecting cardiac nerves and ganglia. Molecular analysis of sudden unexplained death genes identified a heterozygous mutation in myosin light chain 2, which was also found in two other healthy members of the family. Additional expert interpretation of the cardiac histology confirmed the absence of arrhythmogenic right ventricular dysplasia or hypertrophic cardiomyopathy.
CONCLUSIONS
RSV-related sudden death in a normally developing child of this age is exceptional. This case highlights the risk of extrapulmonary manifestations associated with this infection, particularly arrhythmia induced by inflammatory phenomena affecting the cardiac autonomic nervous system. The role of the mutation in this context is uncertain, and it is therefore necessary to continue to assess how this pathogenic variant contributes to unexpected sudden death in childhood.

Identifiants

pubmed: 31771554
doi: 10.1186/s12887-019-1847-2
pii: 10.1186/s12887-019-1847-2
pmc: PMC6880595
doi:

Substances chimiques

Myosin Light Chains 0
myosin light chain 2 0
Cardiac Myosins EC 3.6.1.-

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

462

Références

Forensic Sci Med Pathol. 2018 Dec;14(4):515-525
pubmed: 30203237
BMC Infect Dis. 2010 Oct 24;10:305
pubmed: 20969802
J Am Coll Cardiol. 2003 Aug 6;42(3):466-72
pubmed: 12906974
BMJ Open. 2018 Apr 17;8(4):e020883
pubmed: 29666137
Mayo Clin Proc. 2008 Jun;83(6):630-8
pubmed: 18533079
Pediatrics. 2016 Dec;138(6):
pubmed: 27940684
Cardiol Young. 2013 Apr;23(2):299-300
pubmed: 22694896
Clin Genet. 2014 Oct;86(4):355-60
pubmed: 24111713
Forensic Sci Int. 2014 Jun;239:27-30
pubmed: 24727219
Crit Care. 2006;10(4):159
pubmed: 16934132
J Clin Microbiol. 2002 Mar;40(3):817-20
pubmed: 11880399
Acta Paediatr. 2004 Jul;93(7):887-90
pubmed: 15303802
Minerva Anestesiol. 2011 Jan;77(1):46-53
pubmed: 21102401
Arch Dis Child. 2019 Oct;104(10):989-993
pubmed: 31005897
Pediatr Crit Care Med. 2000 Oct;1(2):146-50
pubmed: 12813266
Biochemistry. 2013 Feb 19;52(7):1249-59
pubmed: 23343568
Am J Hum Genet. 2011 Feb 11;88(2):183-92
pubmed: 21310275
Case Rep Infect Dis. 2017;2017:7074508
pubmed: 28567315
Pol Arch Intern Med. 2018 Dec 21;128(12):721-730
pubmed: 30403391
Pediatr Cardiol. 1996 May-Jun;17(3):163-8
pubmed: 8662029
Cardiol Young. 2010 Feb;20(1):103-4
pubmed: 20178680
Jpn Heart J. 1981 May;22(3):447-54
pubmed: 7265470
Transpl Infect Dis. 2013 Aug;15(4):E152-6
pubmed: 23725410
Crit Care Med. 1997 May;25(5):880-6
pubmed: 9187611
J Forensic Sci. 1991 Nov;36(6):1760-4
pubmed: 1770344
Europace. 2010 Mar;12(3):347-55
pubmed: 20173211
J Pediatr. 1994 Jul;125(1):23-8
pubmed: 8021780
J Investig Med. 1997 Oct;45(8):469-73
pubmed: 9394100
Neth Heart J. 2018 Oct;26(10):500-505
pubmed: 30178211
Forensic Sci Med Pathol. 2016 Mar;12(1):4-13
pubmed: 26782961
Paediatr Respir Rev. 2010 Dec;11(4):219-25
pubmed: 21109180
J Paediatr Child Health. 1993 Aug;29(4):309-11
pubmed: 8373680
Pediatrics. 2017 Mar;139(3):
pubmed: 28228502
Europace. 2014 Dec;16(12):1706-13
pubmed: 24585884
Pediatr Emerg Care. 1994 Aug;10(4):219-21
pubmed: 7937300
BMC Pediatr. 2018 Feb 12;18(1):51
pubmed: 29433478
Crit Care. 2006;10(4):R107
pubmed: 16859512
Am J Emerg Med. 2003 Oct;21(6):479-82
pubmed: 14574656
Forensic Sci Int. 2006 Aug 10;161(1):8-14
pubmed: 16300916
Pediatr Pulmonol. 2017 Oct;52(10):E61-E63
pubmed: 28486756
J Am Coll Cardiol. 1983 Nov;2(5):983-1002
pubmed: 6355239

Auteurs

A Gavotto (A)

Pediatric and Congenital Cardiology Department, Arnaud de Villeneuve Hospital, Montpellier University Hospital Center, Montpellier, France.
CNRS UMR 9214, INSERM U1046, University of Montpellier, Montpellier, France.

A Ousselin (A)

Department of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve Hospital, Montpellier University Hospital Center, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France.

O Pidoux (O)

Department of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve Hospital, Montpellier University Hospital Center, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France.

P Cathala (P)

Department of Forensic Medicine, Lapeyronie Hospital, Montpellier University Hospital Center, Montpellier, France.

V Costes-Martineau (V)

Department of Pathology, Lapeyronie Hospital, Montpellier University Hospital Center, Montpellier, France.

B Rivière (B)

Department of Pathology, Lapeyronie Hospital, Montpellier University Hospital Center, Montpellier, France.

J L Pasquié (JL)

Department of Cardiology, Arnaud de Villeneuve Hospital, Montpellier University Hospital Center, Montpellier, France.

P Amedro (P)

Pediatric and Congenital Cardiology Department, Arnaud de Villeneuve Hospital, Montpellier University Hospital Center, Montpellier, France.
CNRS UMR 9214, INSERM U1046, University of Montpellier, Montpellier, France.

C Rambaud (C)

Department of Pathology and Forensic Medicine, Raymond Poincaré Hospital, Garches University Hospital, Garches, France.

G Cambonie (G)

Department of Neonatal Medicine and Pediatric Intensive Care, Arnaud de Villeneuve Hospital, Montpellier University Hospital Center, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France. g-cambonie@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH